Clinical Trial Update: Phase I Trial of VS-6766 Alone and in Combination With Everolimus [Phase 1]

View source ↗

Summary

Completed Phase I trial evaluating VS-6766 alone and in combination with everolimus in patients with solid tumors, multiple myeloma, lung cancer, and ovarian ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Multiple Myeloma
• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• Everolimus (everolimus)
• VS-6766 (VS-6766)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Solid Tumours, Multiple Myeloma | Phase 1 | Status: COMPLETED